Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2000
02/10/2000WO2000006582A1 Trimeric and polymeric alkaloids
02/10/2000WO2000006580A1 Pyridobenzothiazine derivatives and process for producing the same
02/10/2000WO2000006579A2 Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity
02/10/2000WO2000006578A1 Pyridobenzoxazine derivatives and process for producing the same
02/10/2000WO2000006577A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF
02/10/2000WO2000006574A1 NOVEL C-2 S/O- AND S/N FORMALDEHYDE ACETAL DERIVATIVES OF CARBAPENEM-3-CARBOXYLIC ACIDS AND THEIR USE AS ANTIBIOTICS AND β-LACTAMASE INHIBITORS
02/10/2000WO2000006572A1 Bensoquinolizine derivatives and process for producing the same
02/10/2000WO2000006571A1 Pyrroloquinoline derivatives and process for producing the same
02/10/2000WO2000006570A1 Triazolopyridines for the treatment of thrombosis disorders
02/10/2000WO2000006569A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
02/10/2000WO2000006568A1 Substituted pyrazole derivatives
02/10/2000WO2000006567A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine
02/10/2000WO2000006563A1 Substituted imidazoles having cytokine inhibitory activity
02/10/2000WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
02/10/2000WO2000006558A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them
02/10/2000WO2000006555A1 Substituted quinazoline derivatives
02/10/2000WO2000006554A1 Lipid-lowering quinazoline derivative
02/10/2000WO2000006545A1 High affinity ligands for nociceptin receptor orl-1
02/10/2000WO2000006544A1 Cyclic amine derivatives and process for the preparation thereof
02/10/2000WO2000006542A1 Oxidised sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents
02/10/2000WO2000006541A1 Sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents
02/10/2000WO2000006534A1 Compounds and compositions for delivering active agents
02/10/2000WO2000006531A2 Nitric esters and nitrate salts of specific drugs
02/10/2000WO2000006529A1 Diketoacid-derivatives as inhibitors of polymerases
02/10/2000WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
02/10/2000WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
02/10/2000WO2000006202A1 Virucide drug containing iodine
02/10/2000WO2000006188A1 Hair growth/maintenance compositions and methods involving the same
02/10/2000WO2000006184A1 Pulmonary delivery of active agents
02/10/2000WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT
02/10/2000WO2000006182A1 Use of extracts from aristolochia in the treatment of aids
02/10/2000WO2000006177A1 Autoinducer synthase modulating compounds and uses therefor
02/10/2000WO2000006175A1 Use of biogenic estrogen sulfamates for hormone replacement therapy
02/10/2000WO2000006174A1 Methods for increasing cytidine levels in vivo and treating cytidine-dependent human diseases
02/10/2000WO2000006172A1 Treatment of equine protozoan myeloencephalitis using triazinediones
02/10/2000WO2000006171A1 Antioxidant composition and method of treating diseases using same
02/10/2000WO2000006170A1 Inhibitors of herpesvirus gene expression, replication and pathogenesis
02/10/2000WO2000006169A1 Integrin receptor antagonists
02/10/2000WO2000006168A1 USE OF ALFUZOSIN FOR THE MANUFACTURE OF DRUGS INTENDED FOR THE TREATMENT OF DISORDERS INDUCED BY SMOOTH MUSCLE CONTRACTION IN THE URINARY TRACT, EXCLUDING CONTRACTION OF α-ADRENERGIC ORIGIN
02/10/2000WO2000006167A1 Tricyclic compounds
02/10/2000WO2000006165A1 Methods and compositions for treating gastro-esophageal reflux disease
02/10/2000WO2000006163A1 Improved method for treatment of sleep-related respiratory disorders
02/10/2000WO2000006162A1 Agents with antidepressant action, containing pramipexol and a further antidepressant
02/10/2000WO2000006161A1 Prevention of migraine recurrence
02/10/2000WO2000006160A1 Treating depression with a combination of fluoxetine (prozac), pindolol (visken) and buspirone (buspar)
02/10/2000WO2000006159A1 Heterocyclic sulphonamide derivatives
02/10/2000WO2000006158A1 Heterocyclyl sulphonamide derivatives
02/10/2000WO2000006157A1 Sulphonamide derivatives
02/10/2000WO2000006156A1 Amide, carbamate, and urea derivatives
02/10/2000WO2000006154A1 Urokinase production inhibitors, angiogenesis inhibitors and methods of prevention or treatment with both
02/10/2000WO2000006153A1 Propenamides as ccr5 modulators
02/10/2000WO2000006151A1 Sustained release nitric oxide producing agents
02/10/2000WO2000006150A1 Use of creatine compounds for treatment of bone or cartilage cells and tissues
02/10/2000WO2000006149A1 Sulfonamide derivatives
02/10/2000WO2000006148A1 Sulphonamide derivatives
02/10/2000WO2000006147A1 Macrophage scavenger receptor antagonists
02/10/2000WO2000006146A1 Substituted anilide compounds and methods
02/10/2000WO2000006145A1 Methods for treating conditions modulated by lactosylceramide
02/10/2000WO2000006144A1 Pharmaceutical compositions and methods for managing scalp conditions
02/10/2000WO2000006143A1 Chemically induced intracellular hyperthermia
02/10/2000WO2000006142A1 Injectable propofol formulations
02/10/2000WO2000006141A1 Use of xanthophyll to accentuate the effects of estrogen
02/10/2000WO2000006140A2 Use of moclobemide for treating certain phsychiatric and medical disorders
02/10/2000WO2000006139A2 Use of moclobemide and metabolites for treating and preventing substance abuse
02/10/2000WO2000006138A2 Use of moclobemide for treating pain and other diseases
02/10/2000WO2000006137A2 Glucocorticoid-selective anti-inflammatory agents
02/10/2000WO2000006136A2 Therapeutic combination of polyamine with an anticancer agent
02/10/2000WO2000006135A2 Cholinergic agents in the treatment of presbyopia
02/10/2000WO2000006134A2 Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
02/10/2000WO2000006133A2 Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions
02/10/2000WO2000006132A2 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease
02/10/2000WO2000006131A1 Estradiol-containing patch for transdermal administration of hormones
02/10/2000WO2000006130A1 Estradiol-containing patch for transdermal administration of hormones
02/10/2000WO2000006129A1 Tablet for extended release of a drug in the stomach
02/10/2000WO2000006126A1 Rapidly disintegrable solid preparation
02/10/2000WO2000006125A1 Fast dissolving ibuprofen containing compositions having analgesic activity
02/10/2000WO2000006121A1 Medicinal aerosol formulations
02/10/2000WO2000006120A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier
02/10/2000WO2000006118A2 Short contact treatment of acne and photoaging with topical retinoids
02/10/2000WO2000006115A1 Topical compositions containing sialyl sugars and their derivatives
02/10/2000WO2000006091A1 Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
02/10/2000WO2000006088A2 Inhibitors of redox signaling and methods of using same
02/10/2000WO2000006086A2 Use of inhibitors of the activation of cxcr4 receptor by sdf-1 in treating rheumatoid arthritis
02/10/2000WO2000006085A2 Compounds and methods
02/10/2000WO2000006082A2 Treatment of anxiety disorders
02/10/2000WO2000006050A1 Composition for freshening nostrils and sinus cavities
02/10/2000WO2000006032A1 Ultrasonic enhancement of drug injection
02/10/2000WO2000005974A1 Novel chitosan-containing liquid compositions and methods for their preparation and use
02/10/2000WO2000000489A3 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
02/10/2000WO2000000166A3 Improved oral compositions for control and prevention of tartar, oral malodor, plaque and gingivitis
02/10/2000WO1999067254A3 Multi-drug resistant retroviral protease inhibitors and use thereof
02/10/2000WO1999064005A8 Use of molecules that modulate an energy related associated state
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2
02/10/2000WO1999062495A3 Dry powder dispersing apparatus and methods for their use
02/10/2000WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
02/10/2000WO1999061012A3 Therapeutic dinucleotide and derivatives
02/10/2000WO1999059595A9 Progesterone treatment of cancer
02/10/2000WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
02/10/2000WO1999058142A9 Use of anti-prolactin agents to treat proliferative conditions
1 ... 6365 6366 6367 6368 6369 6370 6371 6372 6373 6374 6375 6376 6377 6378 6379 6380 6381 6382 6383 6384 6385 ... 7860